SC
LLY icon

Styrax Capital’s Eli Lilly LLY Stock Holding History

Styrax Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-145,422
Closed -$113M – 11
2025
Q2 		$113M Buy
145,422
+88,074
+154% +$68.4M 8.07% 6
2025
Q1 		$47.4M Sell
57,348
-85,221
-60% -$70.9M 4.41% 9
2024
Q4 		$110M Buy
142,569
+10,228
+8% +$8.47M 9.33% 6
2024
Q3 		$117M Buy
132,341
+12,031
+10% +$10.8M 13.15% 5
2024
Q2 		$109M Hold
120,310
– – 8.33% 4
2024
Q1 		$93.6M Hold
120,310
– – 6.73% 7
2023
Q4 		$70.1M Hold
120,310
– – 6.46% 8
2023
Q3 		$64.6M Buy
120,310
+60,155
+100% +$31M 7.73% 5
2023
Q2 		$28.2M Buy
60,155
+24,062
+67% +$10.1M 3.3% 12
2023
Q1 		$12.4M Sell
36,093
-18,047
-33% -$6.09M 1.94% 13
2022
Q4 		$19.8M Buy
+54,140
New +$19.2M 4.51% 9

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Styrax Capital's LLY Position: Q3 2025 in Review

Styrax Capital sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 145,422 shares — an estimated $113M sold.

Styrax Capital first reported a position in LLY in Q4 2022 and held it in 11 quarters. The position peaked at $117M in Q3 2024. 3,899 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Styrax Capital reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Styrax Capital sold 145,422 Eli Lilly shares in Q3 2025, an estimated $113M.
  • Styrax Capital first reported a position in Eli Lilly in Q4 2022 and held it in 11 quarters.
  • Styrax Capital's Eli Lilly position peaked at $117M in Q3 2024.
  • 3,899 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Styrax Capital's 13F filing for Q3 2025, filed 14 Nov 2025.